Page 161 - 南京医科大学自然版

第46卷第10期 丁紫琪，张 倩. 纳米技术在支气管哮喘诊断和治疗中的研究进展［J］.
2026年10月 南京医科大学学报（自然科学版），2026，46（10）：1584-1592 ·1591 ·

nanoparticles for biomedical applications［J］. Signal T⁃cell and dendritic cell immune responses［J］. Allergy
Transduct Target Ther，2023，8（1）：435 Asthma Clin Immunol，2008，4（3）：95
［27］Ren J，Liu Y，Yao Y，et al. Intranasal delivery of MSC⁃de⁃ ［40］Jang S，Park J W，Cha H R，et al. Silver nanoparticles
rived exosomes attenuates allergic asthma via expanding modify VEGF signaling pathway and mucus hypersecre⁃
IL⁃10 producing lung interstitial macrophages in mice［J］. tion in allergic airway inflammation［J］. Int J Nanomed，
Int Immunopharmacol，2021，91：107288 2012，7：1329-1343
［28］Honmane S，Hajare A，More H，et al. Lung delivery of ［41］Huang J，Bai X，Stewart W，et al. Budesonide⁃incorporated
nanoliposomal salbutamol sulfate dry powder inhalation inhalable lipid nanoparticles for antiTSLP nanobody
for facilitated asthma therapy［J］. J Liposome Res，2019， mRNA delivery to treat steroid⁃resistant asthma［J］. Nat
29（4）：332-342 Commun，2025，16（1）：6013
［29］Wang D，Nasab E M，Athari S S. Study effect of baicalein ［42］Wu Y，Shi W，Wang H，et al. Anti⁃ST2 nanoparticle alle⁃
+
encapsulated/loaded chitosan ⁃ nanoparticle on allergic viates lung inflammation by targeting ILC2s⁃CD4 T re⁃
asthma pathology in mouse model［J］. Saudi J Biol Sci， sponse［J］. Int J Nanomed，2020，15：9745-9758
2021，28（8）：4311-4317 ［43］Wang F，Lou J，Lou X，et al. A Spleen⁃targeted tolerogenic
［30］Chan Y，Raju Allam V S R，Paudel K R，et al. Nutraceuti⁃ mRNA ⁃ LNPs vaccine for the treatment of experimental
cals：unlocking newer paradigms in the mitigation of in⁃ asthma［J］. Adv Sci，2025，12（13）：2412543
flammatory lung diseases［J］. Crit Rev Food Sci Nutr， ［44］Loo C Y，Lee W H. Nanotechnology ⁃ based therapeutics
2023，63（19）：3302-3332 for targeting inflammatory lung diseases［J］. Nanomedi⁃
［31］Hamrick S K，Thompson M A，Rotello V M，et al. Nanopar⁃ cine（Lond），2022，17（12）：865-879
ticles to target asthma［J］. Am J Physiol⁃Lung Cell Mol ［45］Lin H，Li Z，Zelepukin I V，et al. Effects of nanoparticle
Physiol，2024，327（6）：L964-L971 physicochemical properties on macrophage polarization［J］.
［32］Rojekar S，Gholap A D，Togre N，et al. Current status of J Control Release，2025，387：114215
mannose receptor⁃targeted drug delivery for improved anti⁃ ［46］Wang C，Hu X Y，Ji R，et al. Inhaled PAMAM⁃based nano⁃
HIV therapy［J］. J Control Release，2024，372：494-521 formulation prolonged lung retention for alleviating pulmo⁃
［33］Suvarna V，Sawant N，Desai N. A review on recent advances nary inflammation of COPD［J］. Mater Today Bio，2025，
in mannose ⁃ functionalized targeted nanocarrier delivery 32：101845
systems in cancer and infective therapeutics［J］. Crit Rev ［47］Lin J，Chen X，Chen Y，et al. Club cell secretory protein
Ther Drug Carrier Syst，2023，40（2）：43-82 16 promotes cell proliferation and inhibits inflammation
［34］Prabhu P，Fernandes T，Damani M，et al. 2 Receptor spe⁃ and pyroptosis in response to particulate matter 2.5 ⁃ in⁃
cific ligand conjugated nanocarriers：an effective strategy duced epithelial damage in asthmatic mice［J］. J Thorac
for targeted therapy of tuberculosis［J］. Curr Drug Deliv， Dis，2025，17（2）：753
2022，19（8）：830-845 ［48］Kumar M A，Baba S K，Sadida H Q，et al. Extracellular
［35］Xue L，Thatte A S，Mai D，et al. Responsive biomaterials： vesicles as tools and targets in therapy for diseases［J］.
optimizing control of cancer immunotherapy［J］. Nat Rev Signal Transduct Target Ther，2024，9（1）：27
Mater，2024，9（2）：100-118 ［49］Cheng L，Hill A F. Therapeutically harnessing extracellular
［36］Lv C，Li H，Cui H，et al. Solid lipid nanoparticle delivery vesicles［J］. Nat Rev Drug Discov，2022，21（5）：379-399
of rhynchophylline enhanced the efficiency of allergic ［50］Yu Y，Ni M，Zheng Y，et al. Airway epithelial ⁃ targeted
asthma treatment via the upregulation of suppressor of nanoparticle reverses asthma in inhalation therapy［J］. J
cytokine signaling 1 by repressing the p38 signaling Control Release，2024，367：223-234
pathway［J］. Bioengineered，2021，12（1）：8635-8649 ［51］Jang M，Yeom K，Han J，et al. Inhalable mRNA nanoparti⁃
［37］Wang L，Feng M，Li Q，et al. Advances in nanotechnology cle with enhanced nebulization stability and pulmonary
and asthma［J］. Ann Transl Med，2019，7（8）：180 microenvironment infiltration［J］. ACS Nano，2024，18
［38］Miller R L，Grayson M H，Strothman K. Advances in asth⁃ （35）：24204-24218
ma：new understandings of asthma’s natural history，risk ［52］Fan Y，Zhou Y，Zhao J，et al. Advances in inhaled nanopar⁃
factors，underlying mechanisms，and clinical manage⁃ ticle drug delivery for pulmonary disease management［J］.
ment［J］. J Allergy Clin Immunol，2021，148（6）：1430- FASEB J，2025，39（21）：e71191
1441 ［53］Zhang W，Zhang S，Hua L，et al. Targeted knockdown of
［39］Kong X，Hellermann G R，Zhang W，et al. Chitosan inter⁃ epithelial estrogen receptor α to mitigate ferroptosis and
feron⁃γ nanogene therapy for lung disease：modulation of epithelial⁃mesenchymal transition in eosinophilic asth⁃